{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:00:14Z","timestamp":1794718814549,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A previously performed phase III trial on 112 subjects investigating prophylactic nimodipine treatment in vestibular schwannoma (VS) surgery showed no clear beneficial effects on preservation of facial and cochlear nerve functions, though it should be considered that protection of facial nerve function was the primary outcome. However, the risk for postoperative hearing loss was halved in the nimodipine group compared to the control group (OR 0.49; 95% CI 0.18\u20131.30; p = 0.15). Accordingly, this phase III extension trial investigates the efficacy and safety of prophylactic nimodipine for hearing preservation in VS surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a randomized, multi-center, two-armed, open-label phase III trial with blinded expert review and two-stage with interim analysis. Three hundred thirty-six adults with the indication for microsurgical removal of VS (Koos I\u2013IV) and serviceable preoperative hearing (Gardner-Robertson scale (GR) 1\u20133) are assigned to either the therapy (intravenous nimodipine 1\u20132\u2009mg\/h from the day before surgery until the fifth postoperative day and standard of care) or the control group (surgery only and standard of care). The primary endpoint of the trial is postoperative cochlear nerve function measured before discharge according to GR 1\u20133 versus GR 4\u20135 (binary). Hearing function will be determined by pre- and postoperative audiometry with speech discrimination, which will be evaluated by a blinded expert reviewer. Furthermore, patient-reported outcomes using standardized questionnaires will be analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Prophylactic parenteral nimodipine treatment may have a positive effect on hearing preservation in VS surgery and would improve patient\u2019s quality of life. Further secondary analyses are planned. Except for dose-depending hypotension, nimodipine is known as a safe drug. In the future, prophylactic nimodipine treatment may be recommended as a routine medication in VS surgery. VS can be considered as an ideal model for clinical evaluation of neuroprotection, since hearing outcome can be classified by well-recognized criteria. The beneficial effect of nimodipine may be transferable to other surgical procedures with nerves at risk and may have impact on basic research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>EudraCT 2019-002317-19, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00019107\">DRKS00019107<\/jats:ext-link>. 8th May 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05417-z","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:03:13Z","timestamp":1626944593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: study protocol of a randomized multi-center phase III trial\u2014AkniPro 2"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-1487","authenticated-orcid":false,"given":"Christian","family":"Scheller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Leisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"H\u00e4nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kowoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"B\u00f6selt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Rahne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wienke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"5417_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-35422-9","volume-title":"Surgery of cerebellopontine lesions","author":"M Samii","year":"2013","unstructured":"Samii M, Gerganov V. Surgery of cerebellopontine lesions. Berlin Heidelberg: Springer; 2013. https:\/\/doi.org\/10.1007\/978-3-642-35422-9."},{"issue":"5","key":"5417_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1474-4422(10)70087-9","volume":"9","author":"AA Rabinstein","year":"2010","unstructured":"Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010;9(5):504\u201319. https:\/\/doi.org\/10.1016\/S1474-4422(10)70087-9.","journal-title":"Lancet Neurol"},{"issue":"1","key":"5417_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/molecules20011003","volume":"20","author":"K Bork","year":"2015","unstructured":"Bork K, Wurm F, Haller H, Strauss C, Scheller C, Gnanapragassam VS, et al. Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth. Molecules. 2015;20(1):1003\u201313. https:\/\/doi.org\/10.3390\/molecules20011003.","journal-title":"Molecules"},{"issue":"10","key":"5417_CR4","doi-asserted-by":"publisher","first-page":"18453","DOI":"10.3390\/ijms151018453","volume":"15","author":"E Herzfeld","year":"2014","unstructured":"Herzfeld E, Strauss C, Simmermacher S, Bork K, Horstkorte R, Dehghani F, et al. Investigation of the neuroprotective impact of nimodipine on Neuro2a cells by means of a surgery-like stress model. Int J Mol Sci. 2014;15(10):18453\u201365. https:\/\/doi.org\/10.3390\/ijms151018453.","journal-title":"Int J Mol Sci"},{"key":"5417_CR5","doi-asserted-by":"crossref","unstructured":"Herzfeld E, Speh L, Strauss C, Scheller C. Nimodipine but not nifedipine promotes expression of fatty acid 2-hydroxylase in a surgical stress model based on Neuro2a cells. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18050964"},{"issue":"1","key":"5417_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijdevneu.2014.10.005","volume":"40","author":"K Sygnecka","year":"2015","unstructured":"Sygnecka K, Heine C, Scherf N, Fasold M, Binder H, Scheller C, et al. Nimodipine enhances neurite outgrowth in dopaminergic brain slice co-cultures. Int J Dev Neurosci. 2015;40(1):1\u201311. https:\/\/doi.org\/10.1016\/j.ijdevneu.2014.10.005.","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"5417_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/jnnp.2006.113449","volume":"79","author":"B Bischoff","year":"2008","unstructured":"Bischoff B, Romst\u00f6ck J, Fahlbusch R, Buchfelder M, Strauss C. Intraoperative brainstem auditory evoked potential pattern and perioperative vasoactive treatment for hearing preservation in vestibular schwannoma surgery. J Neurol Neurosurg Psychiatry. 2008;79(2):170\u20135. https:\/\/doi.org\/10.1136\/jnnp.2006.113449.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"5417_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0033-1355164","volume":"75","author":"C Scheller","year":"2014","unstructured":"Scheller C, Wienke A, Wurm F, Simmermacher S, Rampp S, Prell J, et al. Neuroprotective efficacy of prophylactic enteral and parenteral nimodipine treatment in vestibular schwannoma surgery: a comparative study. J Neurol Surg A Cent Eur Neurosurg. 2014;75(4):251\u20138. https:\/\/doi.org\/10.1055\/s-0033-1355164.","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"1","key":"5417_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1227\/01.neu.0000279728.98273.51","volume":"61","author":"C Scheller","year":"2007","unstructured":"Scheller C, Richter HP, Engelhardt M, K\u00f6enig R, Antoniadis G. The influence of prophylactic vasoactive treatment on cochlear and facial nerve functions after vestibular schwannoma surgery: a prospective and open-label randomized pilot study. Neurosurgery. 2007;61(1):92\u20137; discussion 97-98. https:\/\/doi.org\/10.1227\/01.neu.0000279728.98273.51.","journal-title":"Neurosurgery"},{"issue":"3","key":"5417_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0032-1313724","volume":"73","author":"C Scheller","year":"2012","unstructured":"Scheller C, Vogel AS, Simmermacher S, Rachinger JC, Prell J, Strauss C, et al. Prophylactic intravenous nimodipine treatment in skull base surgery: pharmacokinetic aspects. J Neurol Surg A Cent Eur Neurosurg. 2012;73(3):153\u20139. https:\/\/doi.org\/10.1055\/s-0032-1313724.","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"2","key":"5417_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0033-1337608","volume":"75","author":"C Scheller","year":"2014","unstructured":"Scheller C, Wienke A, Wurm F, Vogel AS, Simmermacher S, Prell J, et al. Enteral or parenteral nimodipine treatment: a comparative pharmacokinetic study. J Neurol Surg A Cent Eur Neurosurg. 2014;75(2):84\u201390. https:\/\/doi.org\/10.1055\/s-0033-1337608.","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"5","key":"5417_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3171\/jns.2001.95.5.0771","volume":"95","author":"C Strauss","year":"2001","unstructured":"Strauss C, Bischoff B, Neu M, Berg M, Fahlbusch R, Romst\u00f6ck J. Vasoactive treatment for hearing preservation in acoustic neuroma surgery. J Neurosurg. 2001;95(5):771\u20137. https:\/\/doi.org\/10.3171\/jns.2001.95.5.0771.","journal-title":"J Neurosurg"},{"issue":"3","key":"5417_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-2004-816268","volume":"65","author":"C Scheller","year":"2004","unstructured":"Scheller C, Strauss C, Fahlbusch R, Romst\u00f6ck J. Delayed facial nerve paresis following acoustic neuroma resection and postoperative vasoactive treatment. Zentralbl Neurochir. 2004;65(3):103\u20137. https:\/\/doi.org\/10.1055\/s-2004-816268.","journal-title":"Zentralbl Neurochir"},{"issue":"3","key":"5417_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1227\/01.NEU.0000230260.95477.0A","volume":"59","author":"C Strauss","year":"2006","unstructured":"Strauss C, Romst\u00f6ck J, Fahlbusch R, Rampp S, Scheller C. Preservation of facial nerve function after postoperative vasoactive treatment in vestibular schwannoma surgery. Neurosurgery. 2006;59(3):577\u201384; discussion 577-584. https:\/\/doi.org\/10.1227\/01.NEU.0000230260.95477.0A.","journal-title":"Neurosurgery"},{"issue":"3","key":"5417_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3171\/2015.1.JNS142001","volume":"124","author":"C Scheller","year":"2016","unstructured":"Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, et al. Prophylactic nimodipine treatment for cochlear and facial nerve preservation after vestibular schwannoma surgery: a randomized multicenter phase III trial. J Neurosurg. 2016;124(3):657\u201364. https:\/\/doi.org\/10.3171\/2015.1.JNS142001.","journal-title":"J Neurosurg"},{"issue":"6","key":"5417_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3171\/2016.8.JNS16626","volume":"127","author":"C Scheller","year":"2017","unstructured":"Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, et al. Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, phase III trial and its pilot study. J Neurosurg. 2017;127(6):1376\u201383. https:\/\/doi.org\/10.3171\/2016.8.JNS16626.","journal-title":"J Neurosurg"},{"issue":"1","key":"5417_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/000348948809700110","volume":"97","author":"G Gardner","year":"1988","unstructured":"Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97(1):55\u201366. https:\/\/doi.org\/10.1177\/000348948809700110.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1-4","key":"5417_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF01401974","volume":"92","author":"WT Koos","year":"1988","unstructured":"Koos WT. Criteria for preservation of vestibulocochlear nerve function during microsurgical removal of acoustic neurinomas. Acta Neurochir (Wien). 1988;92(1-4):55\u201366. https:\/\/doi.org\/10.1007\/BF01401974.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"5417_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","volume":"113","author":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re\u2019s disease","year":"1995","unstructured":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re\u2019s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995;113(3):181\u20135. https:\/\/doi.org\/10.1016\/S0194-5998(95)70102-8.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5417_CR20","volume-title":"Deutsche Version des Short Form-36 Health Survey","author":"SF-36 Fragebogen zum Gesundheitszustand","year":"2011","unstructured":"SF-36 Fragebogen zum Gesundheitszustand. Deutsche Version des Short Form-36 Health Survey. G\u00f6ttingen: Hogrefe; 2011."},{"issue":"3","key":"5417_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"issue":"11","key":"5417_CR22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00701-017-3304-z","volume":"159","author":"J Kristin","year":"2017","unstructured":"Kristin J, Glaas MF, Stenin I, Albrecht A, Klenzner T, Schipper J, et al. Multistep translation and cultural adaptation of the Penn acoustic neuroma quality-of-life scale for German-speaking patients. Acta Neurochir (Wien). 2017;159(11):2161\u20138. https:\/\/doi.org\/10.1007\/s00701-017-3304-z.","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"5417_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00106-017-0334-z","volume":"65","author":"S Moser","year":"2017","unstructured":"Moser S, Luxenberger W, Freidl W. Perception of hearing problems in the older population. Hno. 2017;65(8):671\u20139. https:\/\/doi.org\/10.1007\/s00106-017-0334-z.","journal-title":"Hno"},{"issue":"3","key":"5417_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00003446-198205000-00006","volume":"3","author":"IM Ventry","year":"1982","unstructured":"Ventry IM, Weinstein BE. The hearing handicap inventory for the elderly: a new tool. Ear Hear. 1982;3(3):128\u201334. https:\/\/doi.org\/10.1097\/00003446-198205000-00006.","journal-title":"Ear Hear"},{"issue":"5","key":"5417_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3171\/2015.10.JNS15926","volume":"125","author":"C Scheller","year":"2016","unstructured":"Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, et al. Stability of hearing preservation and regeneration capacity of the cochlear nerve following vestibular schwannoma surgery via a retrosigmoid approach. J Neurosurg. 2016;125(5):1277\u201382. https:\/\/doi.org\/10.3171\/2015.10.JNS15926.","journal-title":"J Neurosurg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05417-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:15:28Z","timestamp":1626945328000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5417"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05417-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical trial will be conducted and reported in compliance with GCP and the applicable national laws and regulations and with the ethical principles laid down in the Declaration of Helsinki to assure that the rights, safety, and well-being of the participating subjects are protected.The clinical trial protocol and any required documents were approved by the German Competent Authority, by the Ethics Committee of the University of Halle-Wittenberg, Germany (reference number 2020-011), and by independent Ethics Committees of all trial sites before the trial start.Participation in the clinical trial is voluntary for all patients. All patients are informed about the nature, significance, and scope of the study; possible benefits and risks of the treatment; the rights and responsibilities of study participants; and the transmission of collected data by the investigator.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All investigational materials and data will be pseudonymized with a unique patient ID before submission to the sponsor and scientific processing. The data has to be saved at least for 10\u2009years in accordance with GCP regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}